S
Silvia Bullitta
Researcher at University of Rome Tor Vergata
Publications - 26
Citations - 1206
Silvia Bullitta is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Experimental autoimmune encephalomyelitis & Multiple sclerosis. The author has an hindex of 14, co-authored 26 publications receiving 770 citations.
Papers
More filters
Journal ArticleDOI
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis
Georgia Mandolesi,Antonietta Gentile,Alessandra Musella,Diego Fresegna,Francesca De Vito,Silvia Bullitta,Helena Sepman,Girolama Alessandra Marfia,Diego Centonze +8 more
TL;DR: Light is shed on the connection between inflammation and synaptopathy in MS and EAE, which sheds light not only on the pathophysiology of MS but also on that of primary neurodegenerative disorders in which inflammatory processes contribute to disease progression.
Journal ArticleDOI
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
Francesca Romana Rizzo,Alessandra Musella,Francesca De Vito,Diego Fresegna,Silvia Bullitta,Valentina Vanni,Livia Guadalupi,Mario Stampanoni Bassi,Fabio Buttari,Georgia Mandolesi,Diego Centonze,Antonietta Gentile +11 more
TL;DR: Current evidence of the role of IL-1β and TNF in the regulation of synaptic strength at both physiological and pathological levels are introduced and discussed, in particular speculating on their involvement in the synaptic plasticity changes observed in the EAE brain.
Journal ArticleDOI
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Antonietta Gentile,Alessandra Musella,Silvia Bullitta,Diego Fresegna,Francesca De Vito,Roberta Fantozzi,Eleonora Piras,Francesca Gargano,Giovanna Borsellino,Luca Battistini,Anna Schubart,Georgia Mandolesi,Diego Centonze +12 more
TL;DR: Results show that siponimod has neuroprotective effects in the CNS of EAE mice, which are likely independent of its peripheral immune effect, suggesting that this drug could be effective in limiting neurodegenerative pathological processes in MS.
Journal ArticleDOI
Interleukin-1β Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis
Georgia Mandolesi,Alessandra Musella,Antonietta Gentile,Giorgio Grasselli,Nabila Haji,Helena Sepman,Diego Fresegna,Silvia Bullitta,Francesca De Vito,Gabriele Musumeci,Claudio Di Sanza,Piergiorgio Strata,Diego Centonze +12 more
TL;DR: The results highlight the crucial role played by the proinflammatory IL-1β in triggering molecular and synaptic events involved in neurodegenerative processes that characterize neuroinflammatory diseases such as MS.
Journal ArticleDOI
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Georgia Mandolesi,Francesca De Vito,Alessandra Musella,Antonietta Gentile,Silvia Bullitta,Diego Fresegna,Helena Sepman,Claudio Di Sanza,Nabila Haji,Francesco Mori,Fabio Buttari,Emerald Perlas,Maria Teresa Ciotti,Eran Hornstein,Irene Bozzoni,Irene Bozzoni,Carlo Presutti,Diego Centonze +17 more
TL;DR: The role of glutamate excitotoxicity in the development and progression of MS and of its mouse model EAE is suggested and miR-142-3p is identified as a determinant molecular actor in inflammation-dependent synaptopathy typical of both MS and EAE.